KACTUS Blog

Base Therapeutics and KACTUS Announce Strategic Partnership with Synthego to Advance GMP AccuBase™ Base Editing Platform

Base Therapeutics and KACTUS Announce Strategic Partnership with Synthego to Advance GMP AccuBase™ Base Editing Platform

The Notorious KRAS

The Notorious KRAS

The Silent Saboteur: Endotoxin Contamination and Its Impact on Your Research Data

The Silent Saboteur: Endotoxin Contamination and Its Impact on Your Research Data

The Rise of Allogeneic Cell Therapies: Strategies, Challenges, and Clinical Advances

The Rise of Allogeneic Cell Therapies: Strategies, Challenges, and Clinical Advances

Cracking KRAS: How TCR-T and TCR-Mimic Antibodies Are Changing KRAS Mutant Cancers

Cracking KRAS: How TCR-T and TCR-Mimic Antibodies Are Changing KRAS Mutant Cancers

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

Immunotherapy Target: CD19 Antigen

Immunotherapy Target: CD19 Antigen

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

2024 Milestones in CRISPR Clinical Pipelines

2024 Milestones in CRISPR Clinical Pipelines

1 2

KACTUS Blog

↑